Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers

PRAVINCHANDRA P. PATEL, MD P.C.

NPI: 1457527475 · COLDWATER, MS 38618 · Family Medicine Physician · NPI assigned 04/30/2008

$2.21M
Total Medicaid Paid
235,689
Total Claims
186,290
Beneficiaries
112
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialPATEL, PRAVINCHANDRA (DR.)
NPI Enumeration Date04/30/2008

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 17,695 $366K
2019 18,074 $377K
2020 16,885 $331K
2021 59,751 $418K
2022 62,436 $293K
2023 30,978 $237K
2024 29,870 $185K

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 31,530 24,957 $1.04M
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 24,236 18,878 $711K
94760 30,854 21,303 $87K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 1,268 958 $68K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular 8,334 6,487 $47K
85025 Blood count; complete (CBC), automated, and automated differential WBC count 9,097 7,846 $26K
94681 826 804 $18K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 1,754 1,656 $15K
20610 1,518 1,114 $14K
94375 816 793 $13K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 173 141 $11K
36415 Collection of venous blood by venipuncture 12,565 10,712 $11K
81000 7,875 6,815 $10K
83036 Hemoglobin; glycosylated (A1C) 4,634 4,066 $10K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 1,256 1,138 $10K
99215 Prolong outpt/office vis 186 169 $10K
94200 826 804 $9K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 846 675 $8K
86403 856 832 $7K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 436 391 $7K
71046 Radiologic examination, chest; 2 views 642 590 $6K
80305 2,449 2,275 $6K
90686 1,315 1,150 $6K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe 315 229 $6K
G2023 Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source 857 656 $6K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine 344 336 $5K
J1040 Injection, methylprednisolone acetate, 80 mg 1,286 984 $4K
G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) 1,760 1,657 $4K
99407 680 529 $4K
76770 69 68 $3K
J1885 Injection, ketorolac tromethamine, per 15 mg 4,517 3,687 $3K
1125F 15,660 12,556 $2K
90674 176 171 $2K
87637 Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV 21 15 $2K
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 20 19 $1K
3075F 5,548 4,334 $1K
J1100 Injection, dexamethasone sodium phosphate, 1 mg 5,391 4,326 $1K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete 28 28 $1K
93000 177 170 $1K
87400 98 78 $984.07
76700 Ultrasound, abdominal, real time with image documentation; complete 12 12 $802.64
90756 69 67 $752.07
72100 39 38 $701.25
3074F 11,257 8,228 $652.75
94664 99 97 $613.25
76536 12 12 $571.74
99354 14 13 $469.64
J3420 Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 719 552 $445.13
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 34 17 $384.80
73560 25 25 $361.91
99406 91 90 $353.77
J0696 Injection, ceftriaxone sodium, per 250 mg 330 270 $260.45
G8752 Most recent systolic blood pressure < 140 mmhg 1,557 1,202 $230.62
83880 18 16 $211.98
99497 333 269 $211.62
96127 178 176 $197.87
3077F 6,355 4,883 $189.43
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 234 175 $153.57
G8753 Most recent systolic blood pressure >= 140 mmhg 590 481 $146.80
85610 273 196 $126.62
J1010 Injection, methylprednisolone acetate, 1 mg 163 135 $104.00
3044F 1,017 861 $71.22
99080 365 315 $69.68
84484 18 16 $67.32
85379 18 16 $61.08
G0008 Administration of influenza virus vaccine 1,039 936 $55.03
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc 41 29 $46.20
3078F 9,896 7,466 $43.74
90656 12 12 $33.44
94761 18 17 $32.42
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg 274 143 $26.97
3079F 10,619 7,868 $24.07
82553 18 16 $23.10
G8754 Most recent diastolic blood pressure < 90 mmhg 1,980 1,541 $19.30
G0447 Face-to-face behavioral counseling for obesity, 15 minutes 93 86 $9.48
96160 40 36 $8.28
G9744 Patient not eligible due to active diagnosis of hypertension 24 24 $0.00
1159F 80 78 $0.00
3045F 14 14 $0.00
3288F 267 259 $0.00
G8427 Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications 811 670 $0.00
1160F 68 66 $0.00
1124F 27 27 $0.00
G9991 Patient received any pneumococcal conjugate or polysaccharide vaccine on or after their 19th birthday and before the end of the measurement period 33 27 $0.00
G0444 Annual depression screening, 5 to 15 minutes 39 36 $0.00
4040F 142 111 $0.00
4013F 285 248 $0.00
G8417 Bmi is documented above normal parameters and a follow-up plan is documented 29 29 $0.00
1100F 32 30 $0.00
G8483 Influenza immunization was not administered for reasons documented by clinician (e.g., patient allergy or other medical reasons, patient declined or other patient reasons, vaccine not available or other system reasons) 29 29 $0.00
G8730 Pain assessment documented as positive using a standardized tool and a follow-up plan is documented 41 36 $0.00
G8482 Influenza immunization administered or previously received 33 26 $0.00
0521F 34 31 $0.00
G9899 Screening, diagnostic, film, digital or digital breast tomosynthesis (3d) mammography results documented and reviewed 18 15 $0.00
99442 44 23 $0.00
3080F 2,446 1,983 $0.00
3017F 114 94 $0.00
1170F 422 409 $0.00
G8419 Bmi documented outside normal parameters, no follow-up plan documented, no reason given 67 65 $0.00
1123F 188 150 $0.00
99000 267 217 $0.00
G8420 Bmi is documented within normal parameters and no follow-up plan is required 61 59 $0.00
4010F 213 209 $0.00
S0020 Injection, bupivicaine hydrochloride, 30 ml 205 98 $0.00
G8510 Screening for depression is documented as negative, a follow-up plan is not required 93 92 $0.00
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit 35 35 $0.00
1111F 113 97 $0.00
G8755 Most recent diastolic blood pressure >= 90 mmhg 117 103 $0.00
1126F 82 71 $0.00
J3304 Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg 49 42 $0.00
1006F 63 63 $0.00
3008F 15 15 $0.00